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The efficient exit of HIV-1 particles from cells requires the action of the viral encoded protein Vpu. Vpu-binding protein
(Ubp) is a cellular protein that interacts with both Vpu and the major structural component of the viral capsid (Gag) and
appears to affect the efficiency of particle exit. Elucidation of the function of Ubp and characterization of the spatial
distribution of Ubp may provide information pertinent to understanding the role of Ubp in virus replication. To investigate the
subcellular location of Ubp, and to see whether Vpu affects the intracellular distribution of Gag, we carried out immunoflu-
orescence localization in conjunction with confocal microscopy. Based on this analysis Ubp is present in both the nucleus
and the cytoplasm. In the cytoplasm, Ubp appeared to be associated with microtubules as evidenced by cofluorescence with
tubulin in the absence and in the presence of colchicine. However, cytoskeletal isolation and detergent extraction of cells
resulted in association of Ubp with the soluble fractions, indicating that Ubp is not in tight association with microtubules.
Moreover, flotation gradient analysis demonstrated that Ubp is cytoplasmic and not stably associated with the plasma
membrane. Interestingly, expression of Vpu in cells resulted in redistribution of both Ubp and Gag to a location near the
periphery of the cell. The effect of Vpu on both Ubp and Gag protein has implications for Vpu-mediated particle exit from cells.
© 2001 Elsevier ScienceINTRODUCTION
Retroviral Gag protein is synthesized in the cytoplasm
of virus-infected cells and associates with the cytoplas-
mic side of the plasma membrane by way of a myristy-
lated N-terminal membrane-binding domain (reviewed in
Swanstrom and Wills, 1997). Association with the plasma
membrane and intermolecular Gag–Gag interaction re-
sult in the coalescence of approximately 1500 Gag mol-
ecules into individual viral capsids (Vogt and Simon,
1999). Successful budding of retrovirus particles from the
plasma membrane requires a late domain (L domain)
that is intrinsic to Gag and that is required for functional
association of ubiquitina with Gag (Ott et al., 1998; Pat-
naik et al., 2000; Schubert et al., 2000; Strack et al., 2000).
In the case of the lentivirus HIV-1, the action of the viral
protein U (Vpu) is also required for efficient budding
(Klimkait et al., 1990; Terwilliger et al., 1989).
Vpu is a 16-kDa type I integral membrane phospho-
protein encoded by the HIV-1 accessory gene vpu (Co-
hen et al., 1988; Strebel et al., 1988). In addition to
facilitating particle exit, Vpu promotes the specific deg-
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198radation of the viral receptor, CD4 (Bour et al., 1995;
Schubert et al., 1992).
Ubp (viral protein U-binding protein), is a 34-kDa hu-
man cellular protein that binds to HIV-1 Vpu based on
protein–protein interactions in a yeast GAL4 two-hybrid
screen (Geraghty et al., 1994) and association in vitro and
in vivo (Callahan et al., 1998). In addition to its interaction
with Vpu, Ubp associates with HIV-1 Gag protein. Gag is
the principal structural component of the viral core. Two
lines of evidence are consistent with functional interac-
tion between these viral proteins and Ubp. First, overex-
pression of Ubp in HIV-1 producing cells significantly
reduces the amount of virus released from the cell, and
second, in vivo association of Ubp with Gag is abrogated
when Vpu is expressed in the cell (Callahan et al., 1998).
Independent experiments indicate that Ubp also inter-
acts with proteins of the parvovirus family (Cziepluch et
al., 1998). Ubp, designated SGT in that report (for small
glutamine-rich tetratricopeptide repeat containing pro-
tein), interacts with the nonstructural viral protein, NS1, of
parvovirus H1. NS1 is a nuclear protein that functions in
parvovirus DNA replication and transcriptional gene ex-
pression. Thus, if Ubp/SGT affects NS1 function, that
interaction may occur in the nucleus of parvovirus-in-
fected cells. In contrast, Vpu and Gag are membrane-
associated and cytoplasmic proteins, respectively.
Therefore, cytoplasmic Ubp–Vpu and Ubp–Gag interac-
tion is more relevant for HIV-1.
Ubp contains four tetratricopeptide repeat sequences
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tandem array beginning 41 residues from the end of the
first TPR (see Fig. 1). TPR motifs are found in proteins
from a wide range of organisms and are present in
diverse proteins that have an array of cellular functions.
TPR motifs are a specific class of amphipathic alpha-
helices mediating inter- or intramolecular protein–pro-
tein interaction in a “lock and key” type fashion (Goebl
and Yanagida, 1991; Lamb et al., 1995; Sikorski et al.,
1991; van der Voorn and Ploegh, 1992). Thus, the four
TPR motifs of Ubp may promote protein–protein associ-
ation. In Ubp, the carboxyl 118 residues, starting after the
fourth TPR, constitute a glutamine-rich sequence with
glutamine comprising 13% of the amino acid residues.
This region of the protein contains no significant homol-
ogy, based on BLAST search analysis, with any known
protein sequence, with the exception of apparent Cae-
norhabditis elegans, Saccharomyces cerevisiae, and
Drosophila melanogaster Ubp homologs. Moreover, this
118-residue stretch lacks obvious conserved domains as
evidenced by comparison to the Conserved Domain Da-
tabase of RPS-Blast. The only obvious segments of Ubp
that contain homology to characterized proteins reside
exclusively in the TPR regions. Ubp readily self-associ-
ates in an in vitro binding system (Cziepluch et al., 1998;
and Handley, unpublished data). However, the exact sub-
unit composition of the oligomer is unknown.
The purpose of this study was to characterize the
subcellular location of Ubp and Gag in the cell and
compare that intracellular distribution in the presence
and in the absence of Vpu. We chose to study Ubp in
HeLa cells since these cells have been used extensively
to examine both Vpu-mediated CD4 degradation and
HIV-1 particle release, and they are large, easy to visu-
alize cells and contain a clearly discernible cytoplasm.
The results presented here indicate that cytoplasmic
Ubp is associated with microtubules. Moreover, expres-
sion of Vpu in cells results in the redistribution of both
Ubp and Gag to areas in close proximity with the cell
periphery. The data are consistent with the possibility
that Ubp is part of a cytoskeletal-associated protein
complex that is affected by Vpu expression.
RESULTS AND DISCUSSION
Ubp colocalizes with cytoplasmic microtubules
FIG. 1. Structure of Ubp and TPR regions. Schematic representation
of Ubp and the location of the four tetratricopeptide repeat domains of
Ubp (boxes).Preliminary analysis of cells by immunofluorescence
with anti-Ubp antibody and confocal microscopy indi-cated that Ubp is present in the nucleus and in associ-
ation with the cytoplasmic cytoskeleton. Ubp interacts
with the HIV-1 Vpu and Gag proteins. Since both of these
viral proteins reside in the cytoplasm of the infected
cells, and since virus assembly and budding are pro-
cesses that take place in the cytoplasm and at the
plasma membrane, we focused on the location of Ubp in
the cytoplasm. Thus, we looked for colocalization of Ubp
with either actin filaments or microtubules since these
are major constituents of the cytoskeleton. Dual staining
for Ubp and tubulin, or with actin, showed apparent
cofluorescence of Ubp with microtubules and to a lesser
extent with actin filaments (Fig. 2A). The pattern for Ubp
staining in the cytoplasm is shown at higher magnifica-
tion in Fig. 2B. The image shows Ubp to be localized in
a filamentous branching pattern in close association
with bundles of microtubules. Further, the association of
Ubp with microtubules was observed in image sections
taken from successive parallel planes through the cell
(Fig. 3A).
If Ubp is associated with microtubules, depolymeriza-
tion of microtubules might be expected to result in con-
comitant redistribution of cytoplasmic Ubp. To test this
hypothesis, we treated cells with colchicine, a microtu-
bule destabilizing agent. As shown in Fig. 3B, colchicine
treatment resulted in the expected depolymerization of
microtubules and redistribution of apparent tubulin sub-
units to cytoplasmic locations both adjacent to the nu-
cleus and toward the distal regions of the cytoplasm.
Similarly, the cytoplasmic Ubp in these cells was also
changed from association with filamentous branching
networks to positions coincident with tubulin. Addition-
ally, Ubp appeared to maintain colocalization with tubulin
in the area surrounding the nucleus as well as in the
outer cytoplasmic regions of the cells. Nuclear Ubp re-
mained apparently unchanged in the colchicine-treated
cells. These data are consistent with the association
between Ubp and cytoplasmic microtubules.
Cell division results in transient depolymerization and
reestablishment of cytoplasmic microtubules. Thus, we
thought it might be informative to examine the intracyto-
plasmic disposition of Ubp in dividing cells. Figure 3C
depicts Ubp and forming microtubules in newly forming
daughter cells. Interestingly, in these cells Ubp appears
in what seems to be a globular array and without appar-
ent association with microtubules. The presence of this
spherical, microtubule-independent Ubp in dividing cells
may indicate that Ubp dissociates from microtubules
during cell division forming large aggregates in the cy-
toplasm. Since Ubp is cytoskeletally associated in non-
dividing cells, Ubp presumably reassociates with micro-
tubules after formation of the two daughter cells.
To further examine the intracellular distribution of Ubp
we prepared cytoplasmic and nuclear fractions and at-
tempted to detect Ubp using Western analysis. As shown
in Fig. 4A, Ubp was found in both the cytoplasmic and the
ts. (B)
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somewhat more abundant in the cytoplasm than in the
nucleus. This is consistent with the immunofluorescence
and confocal analyses of Ubp.
Cytoplasmic Ubp is not tightly associated with
microtubules
To further explore the interaction between Ubp and
microtubules, we prepared cytoplasmic and nuclear frac-
tions and carried out cytoskeletal fractionation of cells.
For cytoskeletal fractionation, microtubules and actin fil-
aments were stabilized in buffer containing taxol and
phalloidin, extracted from cells, washed, solubilized, and
analyzed by Western blotting (see Materials and Meth-
ods). This fractionation procedure results in a combined
cytoplasmic and soluble membrane fraction and a sep-
arate cytoskeletal fraction. These fractions were ana-
FIG. 2. Ubp colocalization with microtubules. (A) HeLa cells were fixe
Comparison of Ubp and tubulin in the cytoplasm. Tubulin is shown in gr
of both tubulin and Ubp. (Bottom) Comparison of Ubp and actin filamen
of the cell.lyzed using antibody specific for Ubp, tubulin, actin, ki-
nesin, and b-COP. The kinesins are a family of microtu-bule-based motor proteins (Hackney and Jiang, 2001;
Vale and Milligan, 2000) and detection of kinesin served
as a representative control protein that is tightly associ-
ated with microtubules. b-COP (cotamer) is a protein that
helps mediate intracellular membrane trafficking (Con-
treras et al., 2000; Tisdale, 2000); we used b-COP as a
representative control protein associated with cytoplas-
mic intracellular membranes and as a protein that is not
stably associated with the cytoskeleton.
As shown in Fig. 4B, cytoskeletal fractionation re-
vealed that Ubp was exclusively found in the cytoplasmic
fraction (S) and not in the cytoskeletal fraction (I). We also
carried out coimmunoprecipitation experiments using
initial immunoprecipitation with anti-Ubp and anti-tubulin
antibody and subsequent Western analysis of the immu-
noprecipitate with anti-tubulin and anti-Ubp antibody, re-
spectively. In both protocols, there was no detectable
tained with nuclear stain and with antibodies to Ubp and tubulin. (Top)
Ubp is shown in red. In the composite panel, yellow indicates overlap
Higher magnification image of Ubp and microtubules in the cytoplasmd and s
een andstable association between Ubp and tubulin (data not
shown). Taken together, these results indicate that the
ication
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denced by confocal imaging is not a direct association or
is a weak interaction.
Ubp is not stably associated with cellular membranes
Vpu is associated with cellular membranes by way of
an N-terminal hydrophobic membrane anchor. Gag be-
comes associated with the cytoplasmic face of the mem-
brane by way of the “M domain.” Ubp does not have a
contiguous hydrophobic domain that is a candidate that
mediates Ubp association with membranes. However,
since Ubp interacts with both Vpu and Ubp, we wanted to
see whether Ubp can also stably associate with mem-
branes. Flotation gradient analysis results in the fraction-
ation of membranes, which are relatively low in density,
from other components of disrupted cells by flotation in
FIG. 3. Cytoplasmic Ubp and tubulin association. (A) Sections of cell
cells with sections moving up through the cells. (B) Altered Ubp locatio
tubulin of colchicine-treated HeLa cells. (C) Cytoplasmic distribution of
are at the point of separating. The bottom panel shows a higher magnif
not carried out for this set of images.high-percentage sucrose. Proteins that are stably asso-
ciated with cellular membranes can segregate with themembrane fraction. Thus, we subjected disrupted cells
to this fractionation and determined the location of Ubp
in the gradient by Western analysis. In conjunction
with detection of Ubp we assayed for the presence of
the membrane-associated protein, 59-nucleosidase.
As shown in Fig. 5, this technique resulted in the
partition of Ubp to higher density fractions of the
gradient rather than to the membrane-rich fractions
near the top of the gradient. These data indicate that
Ubp is not stably associated with membranes.
Expression of Vpu results in cytoplasmic
redistribution of Gag and Ubp
Deora et al. (2000) found that fusion proteins com-
posed of the MA domain of Gag appended to green
fluorescent protein were located at different intracellular
ed for tubulin, Ubp, and nuclei. The top panel shows the bottom of the
p with colchicine treatment. Immunofluorescence staining of Ubp and
dividing cells. The top panel of images shows two daughter cells that
view of the cytoplasm of a forming daughter cell. Nuclear staining wass stain
n of Ub
Ubp inlocations in the presence and in the absence of Vpu. To
determine whether Vpu expression affects the spatial
202 HANDLEY ET AL.distribution of both Ubp and Gag we transiently ex-
pressed wild-type or vpu2 HIV expression constructs in
HeLa cells and examined the intracellular distribution of
Ubp and full-length Gag. The efficiency of viral particle
release was measured as a control for successful trans-
fection. Typically, Vpu enhances particle exit from 5- to
10-fold. HIV-1 particle release was measured from these
cell populations using an ELISA that quantifies intracel-
lular and extracellular p24 antigen (Callahan et al., 1998)
and calculating the ratio of extra- to intracellular gag
protein. These data indicate that Vpu facilitated particle
exit as expected (data not shown).
Transient transfection of cells results in the successful
introduction of DNA into only a subset of the cell popu-
lation. However, it was possible to readily identify trans-
fected cells and cotransfected cells simply by screening
for the presence or absence of Gag protein expression.
Dual detection of Gag and Ubp in transfected cells, using
antibodies specific for these two proteins in conjunction
with confocal imaging, revealed that both Ubp and Gag
are differentially located in the absence or in the pres-
ence of Vpu. In the absence of Vpu, Ubp was distributed
in the cytoplasm in a manner indistinguishable from that
of untransfected cells (Fig. 6A). Moreover, Gag protein
was generally localized throughout the cytoplasm; Gag
appeared to be situated in an overall uniform distribution
within the cytoplasm but in a large number of local
centers apparently containing higher concentrations of
Gag. In contrast, coexpression of Vpu with Gag resulted
in a striking accumulation of Gag near the plasma mem-
brane (Fig. 6B). Moreover, in the presence of Vpu, Ubp
was also redistributed from a position overlapping with
the cytoskeleton to peripheral regions coincident with
Gag.
To characterize the association of Gag with the cy-
toskeleton, and to determine whether Vpu expression
affected either cytoskeletal or membrane association of
Gag, we carried out cytoskeletal extraction, as in Fig. 4,
and detected Gag using Western analysis. Based on this
assay, Gag appeared to be associated with both the
cytoskeletal (insoluble) and the cytoplasmic (soluble)
fractions (Fig. 7). Furthermore, coexpression of Vpu did
not detectably affect the distribution of Gag with the
cytoskeleton. To see whether Vpu affected the associa-
tion of Gag with membranes, we carried out flotation
gradient analysis of Gag from cells that either coex-
pressed or lacked Vpu. This analysis indicated that most
of the Gag protein was membrane associated and that
the expression of Vpu did not markedly affect the asso-
ciation of Gag with membranes (Fig. 8).
On the nature of association between Ubp and the
cytoskeletonOur confocal data are consistent with association of
Ubp with the cytoskeletal microtubules. However, thefoundation of that association is unclear since Ubp does
not associate stably coimmunoprecipitate with tubulin
and is segregated from the cytoskeletal fraction during in
vitro fractionation. Further, there does not appear to be
indirect interaction between Ubp and the cytoskeleton by
way of cytoskeletal-associated membrane vesicles since
Ubp does not stably associate with membrane fractions
in membrane flotation gradients. These data suggest
that the interaction between Ubp and the cytoskeleton is
tenuous, regardless of whether that interaction is medi-
ated directly or indirectly.
On the interaction between Vpu and Ubp and
between Ubp and Gag
In contrast to Ubp, Vpu is tightly associated with cel-
lular membranes, and Vpu is probably transported to-
ward the plasma membrane by way of Golgi-derived
vesicles that are trafficked along the cytoskeleton. There-
fore, it is likely that Vpu and Ubp interact at the surface
of these actively transported vesicles.
HIV-1 Gag protein is present in cells either in unmyri-
stylated form in the cytoplasm or in myristylated form
largely associated with cellular membranes. In the par-
adigm of retrovirus assembly and budding, myristylation
of Gag is required for membrane association, and inter-
action is generally considered to occur initially and di-
rectly with the plasma membrane. Since Ubp appears to
be associated with the cytoskeleton, it is not obvious
how Gag and Ubp would efficiently encounter each other
for efficient interaction. However, it is also possible that
Gag associates with intracellular membranes. If so, then
this might provide a more efficient mechanism to facili-
tate Ubp–Gag association. It is probably more relevant to
consider the interaction and intracellular location of Ubp
and Gag in the presence of Vpu since all three proteins
are present in virus-infected cells. In the presence of
Vpu, Ubp appears to be displaced from its normal cy-
toskeletal location to a position close to the cell periph-
ery. It is significant that the intracellular distribution of
Gag also appears to change in the presence of Vpu to a
position that overlaps that of Ubp. This Vpu-dependent
intracellular localization of both Ubp and Gag could fa-
cilitate the interaction between Ubp and Gag.
Vpu functions to promote exit of viral capsids from
virus-producing cells. It seems likely that redistribution of
Gag protein to a position adjacent to the plasma mem-
brane as a consequence of Vpu expression is involved in
Vpu-mediated particle exit. The mechanism by which Vpu
effects this redistribution of Gag is unclear. However, the
fact that Vpu and Ubp interact with each other, and that
Ubp and Gag interact with each other, suggests a model
in which Vpu drives the movement of Ubp from microtu-
bules to the cell periphery. The translocation of Ubp
might then result in concomitant redistribution of Gag to
the cell surface.
203Vpu-BINDING PROTEINPreliminary data indicate that Ubp functions as a co-
chaperone, modulating the activity of the multiprotein
chaperone complex (Angeletti and Panganiban, submit-
ted). The association of Ubp with microtubules is con-
sistent with such a function for Ubp. It is possible that
Ubp may be involved in the process of HIV-1 viral particle
assembly, perhaps as a factor that helps shuttle Gag to
the plasma membrane where Gag can readily assemble
into capsids. Alternatively, Ubp may act as a negative
factor in viral particle assembly, whereby binding to Gag
inhibits the proper transport of the protein and reduces
the formation of viral particles at the membrane surface.
This latter hypothesis postulates that the role of Vpu is to
bind Ubp and remove it from interfering with Gag trans-
port to the plasma membrane and/or assembly into viral
particles.
MATERIALS AND METHODS
Cell culture, transfection, and colchicine treatment
HeLa cells were grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum. Eight
hundred microliters of HeLa cells at 5 3 106/ml were
electroporated in 0.4-cm electrode cuvettes at 0.27 kV,
900 mF with 40 mg of plasmid DNA for immunofluores-
cence and with 20 mg DNA for all other experiments. For
colchicine treatment, cells were incubated with 10 mg/ml
FIG. 4. Cytoplasmic, nuclear, and cytoskeletal fractionation and de-
tection of Ubp in HeLa cells. (A) Cytoplasmic and nuclear fractions
were obtained from HeLa cells and analyzed by Western blotting with
affinity-purified anti-Ubp. (B) Cytoskeletal and detergent extraction of
HeLa cells. L, cell lysate; S, soluble fraction (cytoplasmic); I, insoluble
fraction (cytoskeleton). Actin and microtubules were stabilized and
detergent extracted as described under Materials and Methods. Kine-
sin and b-COP were used as controls for microtubule-associated and
membrane-associated proteins, respectively.colchicine (Sigma) in feeding medium for 4 h prior to
immunofluorescence.DNA constructs
G108 and BG135 have been previously described (Cal-
lahan et al., 1998). Briefly, GB108 is a derivative of HIV-1
NL4-3 containing a deletion in the envelope gene. This
construct is referred to as wild-type (WT) in this paper
since the env gene is dispensable for particle formation,
budding, and Vpu responsiveness. BG135 is derived from
GB108 and contains an insertion in the vpu gene that
alters the reading frame after the first 10 amino acids.
This construct is referred to as Vpu2 in this paper.
Immunofluorescence
HeLa cells were plated onto glass cover slides at 20 3
103/ml and incubated overnight prior to staining. Slides
were prepared by being washed in ice-cold PBS 33,
fixed, and permeabilized in 100% methanol for 20 min at
220°C. Cells were then treated for 30 min at room
temperature with blocking buffer (5% dry milk, 20 mM
Tris, 0.01% NaN3). For concurrent imaging of Ubp with
FIG. 5. Flotation gradient analysis of Ubp. Cells were sonicated and
fractionated in a sucrose flotation gradient as described under Mate-
rials and Methods. (A) Measurement of 59-nucleotidase, a plasma
membrane marker, in collected fractions. (B) Western analysis of Ubp.
(C) The efficiency of particle release in the presence and in the
absence of Vpu.
204 HANDLEY ET AL.FIG. 6. Vpu-dependent redistribution of Ubp and Gag. (A) Intracellular distribution of Gag and Ubp in cells lacking Vpu. (B) Intracellular distribution
of Gag and Ubp in cells expressing Vpu.
205Vpu-BINDING PROTEINtubulin or Ubp with actin, cells were incubated with
rabbit anti-Ubp (antigen affinity-purified) diluted in block-
ing buffer for 2 h at 4°C. The slides were then washed
43 with ice-cold PBS. The cells were then incubated
with TRITC-labeled goat anti-rabbit diluted at 1:200 at
room temperature for 1 h. Slides were washed 43 in
PBS, incubated with monoclonal FITC-conjugated anti-
tubulin, 1:200, or monoclonal FITC-labeled anti-actin,
1:100, diluted in blocking buffer, and incubated at room
temperature for 1 h. For Gag staining, antibody KC57-
FITC was diluted 1:100 in blocking buffer and incubated
at room temperature for 1 h. Slides were washed 23 with
PBS, and nuclei were stained with TO-PROTM 3 iodide
(Molecular Probes, T-3605) diluted at 1:10,000 and incu-
bated for 10 min at room temperature. Cells were
washed an additional 33, mounted onto glass micro-
scope slides with anti-fade mounting medium (Molecular
Probes, P-7481), and allowed to dry overnight prior to
viewing.
Confocal microscopy
Slides were imaged using a Bio-Rad MRC1024 laser
scanning confocal microscope (Bio-Rad Microsciences,
Hercules, CA) mounted on a Nikon Optiphot upright
stand using a Nikon 603 NA 1.4 objective lens. Single
optical sections and Z-series of the triple-labeled sam-
ples were imaged simultaneously using the 488-, 568-,
and 647-nm lines of an air-cooled krypton–argon laser.
The images were further processed using Adobe Photo-
shop (Paddock et al., 1997).
Cytoplasmic fractionation and nuclear extraction
This method was performed as described by Cz-
6
FIG. 7. Cytoskeletal fractionation of cells transfected with viral ex-
pression constructs. Annotations and abbreviations are as in Fig. 4.iepluch et al. (1998). Briefly, 5 3 10 HeLa cells were
disrupted in a hypotonic solution (20 mM HEPES–KOH,pH 7.4, 7.5 mM MgCl2, 0.1 mM DTT) using a tight-fitting
Dounce homogenizer and incubated on ice for 20 min.
The homogenate was centrifuged for 5 min at 12,000g
and cytoplasmic supernatant was removed. The result-
ing nuclei-rich pellet was incubated with an equal vol-
ume of hypotonic solution adjusted to 0.5 M NaCl on ice
for 30 min. The nuclear extract was then clarified by
low-speed centrifugation.
Cytoskeleton isolation and detergent extraction
The method used for the isolation of the cytoskeleton
was modified from those reported by Liu et al. (1999).
HeLa cells were collected by trypsinization and normal-
ized to 0.5 3 106 cell/ml. One milliliter of cells was
pelleted, washed 13 with ice-cold PBS, then washed
twice with 50 ml cytoskeleton stabilizing buffer (CSB) [100
mM piperazine-N,N9-bis(2-ethanesulfonic acid) (PIPES;
pH 6.9) with 1 mM EGTA, Taxol, and 66 mg of phalloidin/
ml]. Cells were lysed in 50 ml CSB containing 1% Triton
X-100, 2 mM GTP, aprotinin (2 mg/ml), phenylmethylsul-
fonyl fluoride (50 mg/ml), leupeptin (2 mg/ml). Cell lysates
were centrifuged at 2000g for 5 min and 50 ml of 23
SDS–PAGE sample buffer was added. The supernatant
(cytoplasmic and detergent-soluble membrane fraction)
was removed from the pellets and clarified by centrifu-
gation at 5000g. The remaining pellet was washed twice
with 50 ml CSB lysis buffer and solubilized in 100 ml of 13
SDS–PAGE sample buffer. Samples were heated in a
boiling water bath for 3 min and run on a 10% SDS–PAGE.
Gels were blotted onto PVDF membrane (Immobilon P,
Millipore) and analyzed by Western analysis with anti-
FIG. 8. Association of Gag with cellular membranes in the presence
and in the absence of Vpu. Flotation gradient analysis was performed
as described in the text and as described in the legend to Fig. 5.
206 HANDLEY ET AL.bodies to Ubp, tubulin, actin, kinesin, or b-COP as pre-
viously described (Callahan et al., 1998).
Equilibrium flotation gradient centrifugation
Flotation gradient fractionation was performed as re-
ported by Ono and Freed (1999). HeLa cells were
washed once with ice-cold PBS and collected by scrap-
ing. Transfected cells were harvested 2 days posttrans-
fection. The cells were resuspended in 10 mM Tris–HCl
(pH 7.5) containing 1 mM EDTA (TE), 10% sucrose con-
taining aprotinin (2 mg/ml), phenylmethylsulfonyl fluoride
(50 mg/ml), and leupeptin (2 mg/ml). Cells were disrupted
by sonication with two 15-s bursts, in ice water. Debris
and nuclei were removed by low-speed centrifugation.
Two hundred fifty microliters of clarified supernatant was
mixed with 1.25 ml of 85.5% (wt/vol) sucrose in TE and
placed at the bottom of a centrifuge tube. Seven millili-
ters of 65% (wt/vol) sucrose in TE was then layered on
top of the sample. An additional 3.25-ml layer of 10%
(wt/vol) sucrose in TE was then added to the top of the
tube. The gradients were centrifuged in a Beckman
SW41T at 100,000g for 18 h at 4°C. Ten 1.2-ml fractions
were taken from the top of the tubes and analyzed for
59-nucleotidase activity and by Western blotting for Ubp
or HIV-1 Gag protein.
Antibodies
Production and purification of anti-Ubp have been pre-
viously described (Callahan et al., 1998). The anti-Ubp
used in the experiments described was antigen affinity-
purified. Antibodies purchased from Sigma were as fol-
lows: anti-tubulin FITC-conjugated (T 2168), anti-tubulin
(T 9026), anti-actin FITC-conjugated (F 3777), anti-actin
(A 2547), anti-kinesin (K 1005), anti-b-COP (G 2279).
Western blotting
Samples were mixed with standard SDS–PAGE protein
sample buffer and subjected to electrophoresis on a 10
or 12% SDS polyacrylamide gel. Proteins were trans-
ferred to an Immobilon-P membrane (Millipore) in trans-
fer buffer (27.2 mM Tris, 192 mM glycine, 20% methanol).
Membranes were air-dried at room temperature for 1 h
and then incubated with blocking buffer (5% dry milk, 20
mM Tris, 0.01% NaN3) containing primary antibodies
overnight at 4°C. Membranes were washed three times
in wash buffer (20 mM Tris, 100 mM NaCl, 0.3% Tween
20, 0.05% NaN3) and incubated with secondary antibod-
ies conjugated with alkaline phosphatase for 2 h at room
temperature. Membranes were washed three times with
wash buffer and developed with 5-bromo-4-chloro-3-in-
dolyphosphate-nitroblue tetrazolium (Sigma) for 15 min
at room temperature.ACKNOWLEDGMENTS
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